BRAINSTORM CELL THERAPEUTICS INC. Increase Decrease In Operating Lease Liability
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Increase Decrease In Operating Lease Liability of $5.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $5.00K, a 92.19% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $2.00K, a 50.00% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $8.00K, a 74.19% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $11.00K, a 63.33% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for fiscal 2025 was $87.00K, a 61.11% increase from fiscal 2024.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for fiscal 2024 was $54.00K, a 65.16% decline from fiscal 2023.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for fiscal 2023 was $155.00K.
- BRAINSTORM CELL THERAPEUTICS INC. increase decrease in operating lease liability for fiscal 2022 was -$594.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-14 | $7.00K 10-Q · filed 2026-08-14 | $15.00K derived: sum of 3 quarters · filed 2026-08-14 | $26.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-15 | $10.00K derived: sum of 2 quarters · filed 2026-05-15 | $21.00K derived: sum of 3 quarters · filed 2026-05-15 | $85.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $19.00K derived: sum of 2 quarters · filed 2026-03-31 | $83.00K derived: sum of 3 quarters · filed 2026-08-14 | $87.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $11.00K 10-Q · filed 2025-11-14 | $75.00K derived: sum of 2 quarters · filed 2026-08-14 | $79.00K 10-Q · filed 2025-11-14 | $110.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $64.00K 10-Q · filed 2026-08-14 | $68.00K 10-Q · filed 2026-08-14 | $99.00K derived: sum of 3 quarters · filed 2026-08-14 | $129.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-15 | $35.00K derived: sum of 2 quarters · filed 2026-05-15 | $65.00K derived: sum of 3 quarters · filed 2026-05-15 | $61.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $61.00K derived: sum of 2 quarters · filed 2026-03-31 | $57.00K derived: sum of 3 quarters · filed 2026-03-31 | $54.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $30.00K 10-Q · filed 2025-11-14 | $26.00K derived: sum of 2 quarters · filed 2025-11-14 | $23.00K 10-Q · filed 2025-11-14 | $361.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$4.00K 10-Q · filed 2025-08-14 | -$7.00K 10-Q · filed 2025-08-14 | $331.00K derived: sum of 3 quarters · filed 2025-08-14 | $273.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$3.00K 10-Q · filed 2025-05-15 | $335.00K derived: sum of 2 quarters · filed 2025-05-15 | $277.00K derived: sum of 3 quarters · filed 2025-05-15 | $231.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $280.00K derived: sum of 2 quarters · filed 2025-03-31 | $234.00K derived: sum of 3 quarters · filed 2025-03-31 | $155.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$58.00K 10-Q · filed 2024-11-14 | -$104.00K derived: sum of 2 quarters · filed 2024-11-14 | -$183.00K 10-Q · filed 2024-11-14 | -$131.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$46.00K 10-Q · filed 2024-08-14 | -$125.00K 10-Q · filed 2024-08-14 | -$73.00K derived: sum of 3 quarters · filed 2024-08-14 | -$107.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$79.00K 10-Q · filed 2024-05-14 | -$27.00K derived: sum of 2 quarters · filed 2024-05-14 | -$61.00K derived: sum of 3 quarters · filed 2024-05-14 | -$556.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $18.00K derived: sum of 2 quarters · filed 2024-04-01 | -$477.00K derived: sum of 3 quarters · filed 2024-04-01 | -$594.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$34.00K 10-Q · filed 2023-11-14 | -$529.00K derived: sum of 2 quarters · filed 2023-11-14 | -$646.00K 10-Q · filed 2023-11-14 | -$511.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$495.00K 10-Q · filed 2023-08-14 | -$612.00K 10-Q · filed 2023-08-14 | -$477.00K derived: sum of 3 quarters · filed 2023-08-14 | -$469.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$117.00K 10-Q · filed 2023-05-15 | $18.00K derived: sum of 2 quarters · filed 2023-05-15 | $26.00K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $143.00K derived: sum of 2 quarters · filed 2023-03-30 | -$47.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $8.00K 10-Q · filed 2021-11-15 | -$182.00K 10-Q · filed 2021-11-15 | ||
| 2021-03-31 | -$293.00K 10-Q · filed 2022-05-16 | -$71.00K derived: sum of 2 quarters · filed 2022-05-16 | -$82.00K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $211.00K derived: sum of 2 quarters · filed 2022-03-28 | $161.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$11.00K 10-Q · filed 2021-11-15 | -$61.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |